Antiviral Activity of the Liver-Targeted Nucleotide HCV Polymerase Inhibitor IDX184 Correlates with Trough Serum Levels of the Nucleoside Metabolite in HCV-infected Chimpanzees
44th EASL April 22-26, 2009 Copenhagen, Denmark
Reported by Jules Levin
DN Standring, R Lanford, B Li, RJ Panzo, M Seifer, M Larsson, SS Good
and XJ Zhou
